Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relative Effectiveness and Safety of Pharmacotherapeutic Agents for Patent Ductus Arteriosus (PDA) in Preterm Infants: A National Comparative Effectiveness Research (CER) Project

NCT04347720 is registered in ClinicalTrials.gov with IWK Health Centre as lead sponsor.

NCT NCT04347720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04347720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relative Effectiveness and Safety of Pharmacotherapeutic Agents for Patent Ductus Arteriosus (PDA) in Preterm Infants: A National Comparative Effectiveness Research (CER) Project
Lead sponsor
IWK Health Centre
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
December 31, 2023
Enrollment
1,663 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

extreme prematurity, patent ductus arteriosus